Revolutionising care: Drug-eluting stent platform designed to address edge restenosis скачать в хорошем качестве

Revolutionising care: Drug-eluting stent platform designed to address edge restenosis

Effective, durable options to address faltering dialysis access circuits have remained elusive, leaving a significant unmet need in long-term access maintenance. Until now. Promising interim data have emerged from the prospective, multicentre DEScover trial evaluating the Solaris DE sirolimus-eluting, electrospun polytetrafluoroethylene (PTFE) covered stent for the treatment of failed access circuits, drawing high hopes from leading global vascular specialists that a transformational solution might finally be at hand. "We have never had a drug-eluting platform that directly addressed the issue of edge restenosis, which is where most of these types of devices fail, when they fail," says Peter Schneider (University of California San Francisco, San Francisco, USA). "This is where the Solaris DE platform will have a big impact—it will be a one-of-a-kind."